{"title": "La Agencia Europea del Medicamento desaconseja la cuarta dosis a personas sanas", "author": "EFE", "url": "https://theobjective.com/sociedad/2022-01-18/ema-suministrar-cuarta-dosis/", "hostname": "theobjective.com", "description": "La Agencia Europea de Medicamentos (EMA) consider\u00f3 este martes \"razonable\" empezar a considerar la administraci\u00f3n de una cuarta dosis de vacunas contra la", "sitename": "The Objective", "date": "2022-01-18", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La Agencia Europea del Medicamento desaconseja la cuarta dosis a personas sanas\nS\u00ed ve \u00abrazonable\u00bb considerar la administraci\u00f3n de esta dosis de refuerzo en personas con un sistema inmunitario deprimido\nLa Agencia Europea de Medicamentos (EMA) consider\u00f3 este martes \u00abrazonable\u00bb empezar a considerar la administraci\u00f3n de una cuarta dosis de vacunas contra la covid-19 en personas con un sistema inmunitario deprimido, pero advirti\u00f3 de que no hay datos sobre su necesidad en la poblaci\u00f3n general sana.\nEn una rueda de prensa, Marco Cavaleri, jefe de Estrategia de Vacunaci\u00f3n, asegur\u00f3 que los reguladores de medicamentos en diferentes regiones, incluida la EMA, \u00abest\u00e1n de acuerdo en que la administraci\u00f3n de m\u00faltiples dosis de refuerzo con intervalos cortos en el tiempo no ser\u00eda una soluci\u00f3n sostenible a largo plazo\u00bb.\n\u201cLa administraci\u00f3n repetida de refuerzos con varios intervalos de tiempo cortos podr\u00eda reducir el nivel de anticuerpos que se pueden producir en cada administraci\u00f3n, ya que nuestro sistema inmunol\u00f3gico necesita una cierta cantidad de tiempo para mostrar la respuesta al ant\u00edgeno que se le presenta. Esto, potencialmente, har\u00e1 que la vacunaci\u00f3n sea un poco menos eficiente con el tiempo\u201d, detall\u00f3.\n\u00abNo hay evidencias\u00bb\nCavaleri no incluye aqu\u00ed la tercera dosis, que es el primer refuerzo -que sigue a la vacunaci\u00f3n primaria- y ya se est\u00e1 inyectando a toda la poblaci\u00f3n europea con aval de la EMA, sino a potenciales futuras dosis, incluida la cuarta, de la que \u201cno hay evidencias de estudios cl\u00ednicos o la vida real sobre su necesidad o valor\u201d en la poblaci\u00f3n general.\nSin embargo, en la poblaci\u00f3n con un sistema inmune gravemente deprimido y, \u201caunque todav\u00eda no hay datos disponibles, ser\u00eda razonable que las autoridades de salud p\u00fablica empezaran a considerar la administraci\u00f3n de una cuarta dosis desde ya\u201d para incrementar la protecci\u00f3n.\nSi en el futuro es necesario volver a vacunar, al menos en algunos grupos de riesgo, la EMA subray\u00f3 que los refuerzos podr\u00edan ofrecerse con la llegada del fr\u00edo, como ya se hace con la de la gripe, porque \u00abesto aumentar\u00eda la respuesta de anticuerpos cuando m\u00e1s lo necesitamos\u201d, a diferencia de las dosis consecutivas.\nCavaleri se refiere a las conclusiones de un encuentro entre reguladores de todo el mundo, que estuvo copresidido la semana pasada por la EMA y la Agencia de Medicamentos de Estados Unidos (FDA), en el que todos discutieron cu\u00e1l debe ser la respuesta regulatoria global al virus.\nAnte los altos contagios en Europa debido a la r\u00e1pida propagaci\u00f3n de la variante \u00f3micron, Cavaleri reiter\u00f3 que las vacunas disponibles contra la covid-19 -especialmente tras la administraci\u00f3n del refuerzo- protegen bien contra la enfermedad grave, la hospitalizaci\u00f3n y la muerte tras la infecci\u00f3n, a pesar de que la protecci\u00f3n contra el contagio se vea reducida.\n\u201cLa situaci\u00f3n en el continente sigue siendo muy preocupante, sobre todo vista la alta tasa de contagios que est\u00e1n progresando la enfermedad, lo que est\u00e1 aumentando la presi\u00f3n sobre los hospitales y la atenci\u00f3n primaria\u201d, explic\u00f3.\nPor tanto, lament\u00f3 que solo el 40% de la poblaci\u00f3n adulta en el Espacio Econ\u00f3mico Europeo (EEE) -los 27 de la UE, Islandia, Liechtenstein y Noruega- hayan recibido ya la dosis de refuerzo, y todav\u00eda quedan cerca de un 20% de los ciudadanos sin que se les haya suministrado la pauta completa.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2022/08/124148/contactophoto-0653533637-scaled-e1661517704419.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/efe/", "https://theobjective.com/autor/efe/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&title=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas%20The Objective", "/cdn-cgi/l/email-protection#39064a4c5b535c5a4d046d5c1c0b09494c5c5d5c1c0b0950574d5c4b5c4a584b1717171f5b565d400475581c0b09785e5c575a50581c0b097c4c4b56495c581c0b095d5c551c0b09745c5d505a58545c574d561c0b095d5c4a585a56574a5c53581c0b0955581c0b095a4c584b4d581c0b095d564a504a1c0b09581c0b09495c4b4a5657584a1c0b094a5857584a1c0b09514d4d494a1c0a781c0b7f1c0b7f4d515c565b535c5a4d504f5c175a56541c0b7f4a565a505c5d585d1c0b7f0b090b0b1409081408011c0b7f5c5458144a4c545057504a4d4b584b145a4c584b4d58145d564a504a1c0b7f", "https://theobjective.com/autor/efe/", "https://theobjective.com/autor/efe/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&title=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2022-01-18%2Fema-suministrar-cuarta-dosis%2F&text=La%20Agencia%20Europea%20del%20Medicamento%20desaconseja%20la%20cuarta%20dosis%20a%20personas%20sanas%20The Objective", "/cdn-cgi/l/email-protection#95aae6e0f7fff0f6e1a8c1f0b0a7a5e5e0f0f1f0b0a7a5fcfbe1f0e7f0e6f4e7bbbbbbb3f7faf1eca8d9f4b0a7a5d4f2f0fbf6fcf4b0a7a5d0e0e7fae5f0f4b0a7a5f1f0f9b0a7a5d8f0f1fcf6f4f8f0fbe1fab0a7a5f1f0e6f4f6fafbe6f0fff4b0a7a5f9f4b0a7a5f6e0f4e7e1f4b0a7a5f1fae6fce6b0a7a5f4b0a7a5e5f0e7e6fafbf4e6b0a7a5e6f4fbf4e6b0a7a5fde1e1e5e6b0a6d4b0a7d3b0a7d3e1fdf0faf7fff0f6e1fce3f0bbf6faf8b0a7d3e6faf6fcf0f1f4f1b0a7d3a7a5a7a7b8a5a4b8a4adb0a7d3f0f8f4b8e6e0f8fcfbfce6e1e7f4e7b8f6e0f4e7e1f4b8f1fae6fce6b0a7d3", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/coronavirus/", "https://theobjective.com/etiqueta/dosis-de-refuerzo/", "https://theobjective.com/etiqueta/sanidad/", "https://theobjective.com/etiqueta/vacunacion/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2022-01-25/sanidad-casos-coronavirus-incidencia-desciende/", "https://theobjective.com/sociedad/2022-01-25/sanidad-casos-coronavirus-incidencia-desciende/", "https://theobjective.com/sociedad/2022-01-24/estudio-variante-omicron-ratones/", "https://theobjective.com/sociedad/2022-01-24/estudio-variante-omicron-ratones/", "https://theobjective.com/sociedad/2022-01-24/espana-suma-casos-muertes-covid/", "https://theobjective.com/sociedad/2022-01-24/espana-suma-casos-muertes-covid/", "https://theobjective.com/sociedad/2022-01-25/ue-viajes-certificado-covid-restricciones/", "https://theobjective.com/sociedad/2022-01-25/ue-viajes-certificado-covid-restricciones/", "https://theobjective.com/sociedad/2022-01-24/noruega-no-recomendara-vacunacion-menores/", "https://theobjective.com/sociedad/2022-01-24/dosis-refuerzo-covid-omicron/", "https://theobjective.com/sociedad/2022-01-23/cataluna-restricciones-contagios-covid/", "https://theobjective.com/sociedad/2022-01-24/mitad-contagios-covid-sexta-ola/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}